Comparison of the efficacy of broad-band targeted UVB phototherapy and topical psoralen with targeted UVA phototherapy in localized vitiligo
Citation
Dincer Rota, D., Aksoy Sarac, G., Arca, E., & Onder, M. (2020). Comparison of the efficacy of broad‐band targeted UVB phototherapy and topical psoralen with targeted UVA phototherapy in localized vitiligo. Dermatologic Therapy, 34(1), 1-6. https://doi.org/10.1111/dth.14562Abstract
Aim of the study is to compare efficacy of targeted broad-band UVB phototherapy
and topical psoralen with targeted UVA phototherapy treatments in localized vitiligo for 3 months prospectively. The cases with symmetrical vitiligo lesions were
included in the study. Broad-band targeted UVB was applied on one side and
targeted UVA phototherapy with topical psoralen on the other side. Twenty-two
patients who were diagnosed with localized vitiligo were enrolled in this study.
These cases consisted of 6 (27.3%) females and 16 (72.7%) males aging between
17 and 69 (34.22 ± 14.15). Fifty-four lesions (27 left, 27 right) were compared for
treatments. After the first month of the treatments, the sides of the lesions were
compared in order to evaluate improvement. Percentages of success were 25% for
targeted broad-band UVB microphototherapy and 75% for topical psoralen with
targeted UVA microphototherapy. When the two treatment methods were com pared with each other, a significant difference was found in terms of treatment
response (P = .017). At the end of the third month, the success rates were 37.5%
for targeted broad-band UVB microphototherapy and 62.5% for topical psoralen
with targeted UVA microphototherapy, however a statistically significant differ ence was not determined between the two treatments (P > .05). Both targeted
broad-band UVB phototherapy and topical psoralen with targeted UVA phototherapy provided repigmentation for localized vitiligo at the end of the third month.
Our investigation shows that both treatments are safe and they provide
repigmentation with a limited response.